Albireo Pharma Inc. (ALBO) Event Oct. 31, 2022, 07:34 UTC 43 Albireo Pharma Inc - Albireo Provides Third Quarter 2022 Business Update Comment Full text
Mersana Therapeutics (MRSN) Event Oct. 31, 2022, 07:03 UTC 38 Mersana Therapeutics - Mersana Third Quarter 2022 Earnings Call Comment Full text
Cytokinetics Inc (CYTK) Event Oct. 31, 2022, 06:30 UTC 43 Cytokinetics Announces Three Upcoming Presentations at the American Heart Association Scientific Sessions 2022 Comment Full text
Compugen Ltd (CGEN) Event Oct. 31, 2022, 06:06 UTC 42 Compugen - Compugen Third Quarter 2022 Financial Results and Corporate Update Comment Full text
Nevro Corp. (NVRO) Event Oct. 28, 2022, 23:40 UTC 42 Nevro Corp. Website - Validate Account Comment Full text
Aptinyx Inc. (APTX) Event Oct. 28, 2022, 14:45 UTC 40 Aptinyx Inc. - Aptinyx Reports Third Quarter 2022 Financial Results and Highlights Comment Full text
Biomerica Inc. (BMRA) Event Oct. 28, 2022, 10:40 UTC 43 Biomerica, Inc. - Investor Presentation Comment Full text
Genmab (GMAB) Event Oct. 28, 2022, 06:46 UTC 37 Genmab Announces Submissions of Regulatory Applications for Epcoritamab (DuoBody®-CD3xCD20) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL) and Diffuse Large B-Cell Lymphoma (DLBCL) Comment Full text
Mereo BioPharma (MREO) Event Oct. 28, 2022, 05:11 UTC 41 Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management Comment Full text
Avantor Inc. (AVTR) Event Oct. 28, 2022, 04:06 UTC 44 Avantor - Avantor Third Quarter Earnings Comment Full text